These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33034038)

  • 1. The impact of COVID-19 pandemic on patients with ANCA associated vasculitis.
    Kant S; Morris A; Ravi S; Floyd L; Gapud E; Antichos B; Dhaygude A; Seo P; Geetha D
    J Nephrol; 2021 Feb; 34(1):185-190. PubMed ID: 33034038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing ANCA-associated vasculitis during COVID-19 pandemic: a single-center cross-sectional study.
    Samanta J; Naidu G; Deo P; Mittal S; Prasad CB; Das D; Dhir V; Sharma SK; Ramachandran R; Rathi M; Nada R; Minz RW; Jain S; Sharma A
    Rheumatol Int; 2022 Dec; 42(12):2159-2166. PubMed ID: 35918490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANCA-associated vasculitis in scleroderma: A renal perspective
.
    Kant S; Shah AA; Hummers LK; Wigley FM; Geetha D
    Clin Nephrol; 2018 Dec; 90(6):413-418. PubMed ID: 30106367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis with Severe Kidney Disease.
    Casal Moura M; Irazabal MV; Eirin A; Zand L; Sethi S; Borah BJ; Winters JL; Moriarty JP; Cartin-Ceba R; Berti A; Baqir M; Thompson GE; Makol A; Warrington KJ; Thao V; Specks U; Fervenza FC
    J Am Soc Nephrol; 2020 Nov; 31(11):2688-2704. PubMed ID: 32826324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing ANCA-associated vasculitis during the COVID-19 pandemic: results from an online survey.
    Kopp CR; Naidu G; Misra DP; Deo P; Jakulla RS; Makan K; Maharaj A; Agarwal V; Sharma A
    Rheumatol Int; 2021 Nov; 41(11):1941-1947. PubMed ID: 34427760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H; Lee SM; Manno RL; Seo P; Geetha D
    Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab, Cyclophosphamide, and Corticosteroids for ANCA Vasculitis: The Good, the Bad, and the Ugly.
    Fenoglio R; Roccatello D; Sciascia S
    Kidney Blood Press Res; 2020; 45(6):784-791. PubMed ID: 33045710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
    Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
    Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks and treatment related aspects of COVID-19 infection in patients with ANCA-associated vasculitis.
    Antovic A; Bruchfeld A; Ekland J; Lövström B; Hugelius A; Börjesson O; Knight A; Gunnarsson I
    Scand J Rheumatol; 2023 Jul; 52(4):418-423. PubMed ID: 36124819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Serum Calprotectin (S100A8/A9) Level With Disease Relapse in Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Pepper RJ; Draibe JB; Caplin B; Fervenza FC; Hoffman GS; Kallenberg CG; Langford CA; Monach PA; Seo P; Spiera R; William St Clair E; Tchao NK; Stone JH; Specks U; Merkel PA; Salama AD;
    Arthritis Rheumatol; 2017 Jan; 69(1):185-193. PubMed ID: 27428710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
    Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA
    Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncommon presentations in ANCA vasculitis: clinical characteristics and outcomes.
    Katikineni VS; Kant S; Gapud EJ; Antiochos B; Manno RL; Phillips M; Seo P; Geetha D
    Clin Rheumatol; 2019 Aug; 38(8):2195-2199. PubMed ID: 31037456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rituximab on malignancy risk in patients with ANCA-associated vasculitis.
    van Daalen EE; Rizzo R; Kronbichler A; Wolterbeek R; Bruijn JA; Jayne DR; Bajema IM; Rahmattulla C
    Ann Rheum Dis; 2017 Jun; 76(6):1064-1069. PubMed ID: 27899372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for severe COVID-19 infection and the impact of COVID-19 infection on disease progression among patients with AAV.
    Wang C; Li ZY; Jiang GP; Zhao MH; Chen M
    Clin Exp Med; 2024 Apr; 24(1):88. PubMed ID: 38683496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study.
    Fonseca JA; Gameiro J; Duarte I; Jorge S; Lopes JA
    Nefrologia (Engl Ed); 2021; 41(3):321-328. PubMed ID: 33309337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal disease in ANCA-associated vasculitis].
    Vanhille P; Vrigneaud L; Quéméneur T
    Presse Med; 2012 Mar; 41(3 Pt 1):247-53. PubMed ID: 22265953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis.
    McGregor JG; Hogan SL; Kotzen ES; Poulton CJ; Hu Y; Negrete-Lopez R; Kidd JM; Katsanos SL; Bunch DO; Nachman PH; Falk RJ
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1(Suppl 1):i123-31. PubMed ID: 25805743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANCA-Associated Vasculitis: Core Curriculum 2020.
    Geetha D; Jefferson JA
    Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complications of vasculitis and its treatment.
    King C; Harper L; Little M
    Best Pract Res Clin Rheumatol; 2018 Feb; 32(1):125-136. PubMed ID: 30526892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.